Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers.
about
Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencingRebalancing immune specificity and function in cancer by T-cell receptor gene therapy.Immunological treatment options for locoregionally advanced head and neck squamous cell carcinomaAdoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens.Rapid generation of NY-ESO-1-specific CD4(+) THELPER1 cells for adoptive T-cell therapy.Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity.Safety and Efficacy of Transplantation with Allogeneic Skin Tumors to Treat Chemically-Induced Skin Tumors in MiceAdoptive immunotherapy of cancer using CD4(+) T cells.TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells.Multispectral imaging: a review of its technical aspects and applications in anatomic pathology.CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting.The DC-HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease.Tumor-specific allogeneic cells for cancer therapy.DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models.
P2860
Q27334215-8991312C-A6C4-4BFB-B780-6067856D2F68Q34084756-11449AC0-307E-4150-9A64-FD5587B17E59Q34181954-B4ABC86B-FEA5-4A9E-BF9B-7C6F3E9D9E09Q34590434-F9D7B72F-419B-498B-961F-862343EF92EFQ35799353-7AB0A9EA-EA5A-4582-BAA1-33F4CDE826F8Q36353207-6E0F8BA1-483C-4F65-BF58-C54C79BD3CD5Q37248413-62CEC647-2998-438A-BF7E-C5EF6FA83D96Q37275304-29C229D5-E76E-4FE0-9E7A-D6ABBEFC9A81Q37952806-21442B07-ED10-462E-AD22-4424D47470E1Q38152999-165DC054-0CCA-4276-8E9E-C425DCC1E9AEQ42136462-D8129D27-2CA4-4E8D-AF8F-F030BDAD58E1Q45230468-A119CCBC-803E-4501-906F-0F75A5066919Q50063348-D57D8581-14AF-436B-8629-5886A438B83BQ55322590-6BB6FE01-0504-4F9F-9696-D45EFBE965AD
P2860
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adoptive transfer of allogenei ...... r histocompatibility barriers.
@en
Adoptive transfer of allogenei ...... r histocompatibility barriers.
@nl
type
label
Adoptive transfer of allogenei ...... r histocompatibility barriers.
@en
Adoptive transfer of allogenei ...... r histocompatibility barriers.
@nl
prefLabel
Adoptive transfer of allogenei ...... r histocompatibility barriers.
@en
Adoptive transfer of allogenei ...... r histocompatibility barriers.
@nl
P2093
P2860
P1433
P1476
Adoptive transfer of allogenei ...... or histocompatibility barriers
@en
P2093
Andrea Boni
Chi-Chao Chan
Christian S Hinrichs
Chrystal M Paulos
Claudia Wrzesinski
Luca Gattinoni
Lydie Cassard
Pawel Muranski
Steven A Rosenberg
P2860
P304
P356
10.1182/BLOOD-2008-07-169797
P407
P577
2008-09-17T00:00:00Z